Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Visual cortes--is it a concern?].

M Cordonnier1

  • 1Service d'Ophtalmologie, Hôpital Erasme, Université Libre de Bruxelles, Bruxelles. monique.cordonnier@erasme.ulb.ac.be

Bulletin De La Societe Belge D'Ophtalmologie
|August 28, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atypical case of acute unilateral complete external ophthalmoplegia.

Journal francais d'ophtalmologie·2021
Same author

Congenital stationary night blindness in a patient with mild learning disability due to a compound heterozygous microdeletion of 15q13 and a missense mutation in <i>TRPM1</i>.

Ophthalmic genetics·2021
Same author

Management of congenital lacrimal gland agenesis in a patient with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES).

Journal francais d'ophtalmologie·2021
Same author

Salzmann's nodular degeneration in a patient with Kartagener syndrome.

Journal francais d'ophtalmologie·2020
Same author

[Recent eye surgery].

Revue medicale de Bruxelles·2017
Same author

Postoperative endophthalmitis after cataract surgery from 2009 to 2013: A retrospective analysis at Erasme Hospital.

Journal francais d'ophtalmologie·2017
Same journal

Didactic image poppers maculopathy.

Bulletin de la Societe belge d'ophtalmologie·2014
Same journal

[Marcus Gunn Syndrome. Study of 3 rare cases].

Bulletin de la Societe belge d'ophtalmologie·2014
Same journal

[Ocular manifestations of children living with HIV/AIDS in Kinshasa].

Bulletin de la Societe belge d'ophtalmologie·2014
Same journal

[Management of rhegmatogenous retinal detachment with unseen breaks: about 50 cases].

Bulletin de la Societe belge d'ophtalmologie·2014
Same journal

Long term IOP lowering efficacy of bimatoprost/timolol fixed combination: a 12 month prospective study.

Bulletin de la Societe belge d'ophtalmologie·2014
Same journal

[Palpebral pilomatricoma simulating a chalazion in a young adult].

Bulletin de la Societe belge d'ophtalmologie·2014
See all related articles

Adverse drug reactions can affect the visual cortex, causing cortical blindness, visual hallucinations, or visual aura. This review details drugs linked to visual cortex toxicity.

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Pharmacology

Context:

  • Adverse drug reactions (ADRs) represent a significant clinical challenge.
  • The visual cortex, responsible for processing visual information, can be a target for drug-induced toxicity.
  • Understanding these toxicities is crucial for patient safety and effective treatment.

Purpose:

  • To explore the involvement of the visual cortex in adverse drug reactions.
  • To describe the clinical manifestations of drug-induced visual cortex toxicity.
  • To identify and list drugs associated with potential visual cortex toxicity.

Summary:

  • The visual cortex may be implicated in adverse drug reactions, manifesting as cortical blindness, visual hallucinations, or visual aura without headache.

Related Experiment Videos

  • Specific drugs known to possess potential visual cortex toxicity are identified and discussed.
  • This highlights a critical aspect of neuro-ophthalmic drug safety.

    • Impact:

    • Enhances clinical recognition of drug-induced visual disturbances.
    • Provides a reference for healthcare professionals regarding medications with potential visual cortex toxicity.
    • Contributes to the pharmacovigilance of neurotoxic agents affecting vision.